Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SILO

SILO Pharma Inc

May 13 • 12:36PM ET

0.4002

+0.0042 1.06 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: TNXP LIXT PALI BCDA SABS

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.61	Insider Own	1.69%	Shs Outstand	16.27M	Perf Week	-4.94%
Market Cap	6.51M	Forward P/E	-	EPS next Y	-	Insider Trans	7.43%	Shs Float	15.99M	Perf Month	0.05%
Enterprise Value	-0.35M	PEG	-	EPS next Q	-	Inst Own	7.88%	Short Float	4.83%	Perf Quarter	37.53%
Income	-4.23M	P/S	92.98	EPS this Y	-	Inst Trans	-10.01%	Short Ratio	0.15	Perf Half Y	-14.18%
Sales	0.07M	P/B	0.85	EPS next Y	-	ROA	-56.31%	Short Interest	0.77M	Perf YTD	17.71%
Book/sh	0.47	P/C	0.95	EPS next 5Y	-	ROE	-74.56%	52W High	1.13 -64.58%	Perf Year	-63.62%
Cash/sh	0.42	P/FCF	-	EPS past 3/5Y	33.45% 26.52%	ROIC	-67.05%	52W Low	0.22 81.09%	Perf 3Y	-80.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.00% -	Gross Margin	-1128.89%	Volatility	7.34% 12.03%	Perf 5Y	-96.98%
Dividend TTM	-	EV/Sales	-5.02	EPS Y/Y TTM	48.85%	Oper. Margin	-5936.95%	ATR (14)	0.05	Perf 10Y	-99.20%
Dividend Ex-Date	-	Quick Ratio	11.36	Sales Y/Y TTM	0.00%	Profit Margin	-5863.50%	RSI (14)	44.73	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.36	EPS Q/Q	82.85%	SMA20	-15.08%	Beta	0.75	Target Price	10.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	0.00%	SMA50	-2.34%	Rel Volume	0.04	Prev Close	0.40
Employees	3	LT Debt/Eq	0.00	Earnings	-	SMA200	-17.37%	Avg Volume	5.01M	Price	0.40
IPO	May 13, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	112,306	Change	1.06%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)